BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19212613)

  • 1. Presence of prostate cells in bone marrow biopsies as a sign of micrometastasis in cancer patients.
    Murray NP; Calaf GM; Badínez L
    Oncol Rep; 2009 Mar; 21(3):571-5. PubMed ID: 19212613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy.
    Murray NP; Reyes E; Tapia P; Badinez L; Orellana N; Fuentealba C; Olivares R; Porcell J; Dueñas R
    Int J Mol Med; 2012 Oct; 30(4):896-904. PubMed ID: 22825050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
    Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
    Urol Res; 1999 Aug; 27(4):285-90. PubMed ID: 10460901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
    Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
    Urol Res; 1999 Oct; 27(5):285-90. PubMed ID: 10644227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen-producing cells in the bone marrow of a patient with early-stage prostate cancer.
    D'Amico AV; Matelski H; O'Leary M; Sussman B
    Urology; 1997 Feb; 49(2):279-82. PubMed ID: 9037298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
    BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer.
    Cher ML; de Oliveira JG; Beaman AA; Nemeth JA; Hussain M; Wood DP
    Clin Cancer Res; 1999 Sep; 5(9):2421-5. PubMed ID: 10499613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: flow cytometric methods for detection of bone marrow micrometastases.
    Hussain M; Kukuruga M; Biggar S; Sakr W; Cummings G; Ensley J
    Cytometry; 1996 Mar; 26(1):40-6. PubMed ID: 8809479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone marrow isolated micrometastases of non-small cell lung cancer].
    Dancewicz M; Kowalewski J; Sir J; Pepliński J; Jezierska A
    Pol Merkur Lekarski; 2006 Mar; 20(117):315-7. PubMed ID: 16780264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in disseminated prostate cancer cells.
    Pfitzenmaier J; Ellis WJ; Arfman EW; Hawley S; McLaughlin PO; Lange PH; Vessella RL
    BJU Int; 2006 Jun; 97(6):1309-13. PubMed ID: 16686730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant.
    Mueller P; Carroll P; Bowers E; Moore D; Cher M; Presti J; Wessman M; Pallavicini MG
    Cancer; 1998 Aug; 83(3):538-46. PubMed ID: 9690547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth in semisolid agar of prostate cancer cells obtained from bone marrow aspirates.
    Ahmann FR; Woo L; Hendrix M; Trent JM
    Cancer Res; 1986 Jul; 46(7):3560-4. PubMed ID: 3708587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bone marrow micrometastasis in esophageal cancer patients by immunomagnetic separation.
    Nakamura T; Matsunami K; Hayashi K; Ota M; Ide H; Takasaki K
    Oncol Rep; 2004 May; 11(5):999-1003. PubMed ID: 15069538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detecting bone marrow micrometastasis of gastric cancer by magnetic activated cell sorting combined with fluorescent activated cell sorting].
    Wang GY; Wang SJ; Li Y; Fan LQ; Song ZC; Wang LL; Zhao Q; Jiao ZK; Zhang ZD; Zhao XF; Wang D
    Ai Zheng; 2005 May; 24(5):605-10. PubMed ID: 15890107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do clinically insignificant tumors of the prostate exist?
    Stamatiou K; Alevizos A; Mariolis A; Spiliopoulou C; Alevizou A; Bovis K; Sofras F
    Urol Int; 2008; 81(4):379-82. PubMed ID: 19077395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
    Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
    J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
    Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
    Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.